COMPARATIVE ANALYSIS OF AI INVOLVEMENT IN DRUG REGULATORY AFFAIRS: USA, EU, AND INDIA

Abstract

Artificial Intelligence (AI) is rapidly transforming healthcare and pharmaceutical sectors, including the realm of drug regulatory affairs. Regulatory bodies across the globe are increasingly integrating AI to enhance drug review processes, pharmacovigilance, clinical